Discontinuation of Flovent in Dec 2023: Guidance from DOH
Regarding the discontinuation of Flovent HFA and Diskus expected at the end of 2023, NYSDOH is proactively reviewing the status of medications within NYRx to ensure patients have a seamless transition to available products. The Corticosteroids-Inhaled drug class was reviewed at the September 2023 Drug Utilization Review Board (DURB) Meeting and the DURB recommended to move Alvesco and Arnuity Ellipta to preferred. As a result, NYRx has removed the PA requirement from these two agents and will update the Preferred Drug List (PDL) with the general DURB meeting updates in November. To view other drugs that were reviewed in September, please refer to the DURB September 2023 Meeting Summary. NYSDOH will continue to monitor the supply of brand Flovent HFA in the marketplace and reassess the need to adjust the status of the generic. Flovent Diskus does not have a generic available, as market supply runs out patients will need to be switched to another product.
Note: Prescribers should review and prescribe preferred products whenever possible. The drugs that are preferred generally do not require prior authorization when prescribed according to FDA labeling, unless otherwise indicated. For a resource containing only preferred drugs, please refer to the NYRx Preferred Drug Quick List.
The NYRx Education & Outreach (E&O) team supports NYSDOH with training and education regarding NYRx, the Medicaid Pharmacy Program. The NYRx E&O team serves as a liaison between NYRx and the Medicaid Managed Care Organizations (MCOs) and assists with complex pharmacy cases. In addition, this team offers specialized support to NYRx stakeholders that care for member populations who may have HIV/AIDs, Hemophilia, Substance Use Disorder, Hepatitis C, Serious Mental Illness, or are in Foster Care. To learn more about NYRx E&O, please visit: NYRx E&O Homepage, send an email to [email protected] or call the NYRx E&O Call Center at (833) 967-7310 Monday-Friday 8am-5pm ET.
Share
Health Commerce System – New Enhancements and Security Features The Department of Health is updating its Health Commerce System (HCS) to enhance security and improve user experience. Starting May 9th, 2024, you’ll see improvements to our “Forgot Password” feature and login interface. For further details and assistance, click here.
-
DEA Announces Move to Reclassify Marijuana from Schedule I to Schedule III Colleagues: On April 30, the DEA announced a move to reclassify Marijuana from Schedule I to Schedule III, alongside Ketamine and some anabolic steroids. This would recognize the use of medical marijuana and make it easier to conduct research, but marijuana would not […]
LaughMD App Pioneers Laughter as Billable, Scalable, Evidence-based Medicine LaughMD is improving the approach to healthcare and wellness in hospitals, dialysis clinics and oncology facilities, bringing laughter right to the bedside of patients and into the daily routines of healthcare staff. With a powerful blend of clinical research and innovative technology, LaughMD offers a unique solution to combat […]
-
California and Oregon Push Toward Universal Healthcare California and Oregon, in response to the federal healthcare policy gridlock, have taken significant steps toward establishing universal healthcare coverage. These states have enacted laws that mandate creating publicly financed, universal coverage systems. These reforms promise substantial cost savings and improved healthcare access for all residents. However, the […]
